⌌
⌍
C O N F I D E N T I A L R E P O R T
To: Executive Board ─ Jatari Kemo Supervision
From: Dr. Elisa Hayashi, Lead Scientist
Date: [REDACTED]
Subject: Neurogenesis Project Overview
____ _ _______ ___ _____
Summary: Project 48N
In our latest prototypes of 48N "The Neural Chimera" represents the pinnacle of our advancements in biotechnology and artificial intelligence. Initiated by Jatari Kemo herself, the project aims to expand the capabilities of the human mind and test it's limitations, creating a new frontier in neurological modification and synthetic consciousness.
O B J E C T I V E S
1 Cognitive Enhancement ─ Augmenting and importing human intellect and problem-solving abilities.
2 Memory Expansion ─ Allowing for the storage and retrieval of vast amounts of data across multiple minds.
3 Neural Repair ─ Developing methods to repair and regenerate damaged neural tissue.
4 The Tanaka One Method* ─ Creating a network of human minds that operate and adhere to designated parameters with unified consciousness and empathy.
M E T H O D O L O G Y
Our methodologies involve techniques in neural engineering, bioinformatics, and machine learning (Adhering to the Morgensen Neural Integration Act of 2022.**) . Key procedures include:
1 Neural Mapping ─ Using advanced imaging technologies to create detailed maps of the brain’s neural networks.
2 Bio-Synthetic Interfaces ─ Developing and implanting devices that facilitate compliance to parameters and direct communication between live neurons and connected computer systems.
3 Genetic Engineering ─ Modifying neural cells to improve their performance and integration with synthetic components.
4 AI Integration ─ Designing AI algorithms that can adapt to and enhance communication between multiple active minds.
R E L A T E D E X P E R I E M E N T S
Project Synapse (managed by Team Delta) ─ Adapt bio-compatible cardiovascular nanobots that aid in reducing temperature of the brain.
Biogrid (managed by dr. Idris Morrison)─ An alpha stage program optimizing the body's functions in order to bypass the limitations of it's cells.
C O N C L U S I O N
In reference to previous reports, the continuation of this project and it's associated programs continues to show steady advancement towards meeting the assigned goals.
* (int. term) The Tanaka One Method - in request from dr. Ema Tanaka, the term is to be used strictly internally and in relation to the project until further advancements call for an evaluation from Team Zeta and the Public Relations Department.
** Morgensen Neural Integration Act (2022), 53 NeoTokyo (NT), 2022 TekkPharm Inc. 6580 (TPI) [dir. Claire Morgensen]
End of Report
___ _ ___ __
Dr. Elisa Hayashi
Lead Scientist, Neurogenesis Project
⌎
⌏